Literature DB >> 1505736

A method of enhancing verocytotoxin production by Escherichia coli.

I al-Jumaili1, D A Burke, S M Scotland, H al-Mardini, C O Record.   

Abstract

The number of verocytotoxin producing Escherichia coli (VTEC) present in the faeces during an infection may be very low, making their detection difficult. We report a method for enhancing toxin production by VTEC using mitomycin C as an inducing agent with the aim of improving the detection of VTEC. In pure culture, mitomycin C enhanced toxin production up to 100-fold. When applied to mixed faecal culture, toxin could be detected in mitomycin C treated samples when standard cultures were negative and when substantially fewer verocytotoxin-producing bacteria were present. Use of this method may aid in the detection of VTEC and is appropriate for use in the routine diagnostic laboratory.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505736     DOI: 10.1016/0378-1097(92)90516-q

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

Review 1.  Bacteriophage control of bacterial virulence.

Authors:  Patrick L Wagner; Matthew K Waldor
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin.

Authors:  A Matsushiro; K Sato; H Miyamoto; T Yamamura; T Honda
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

3.  Culture negative cytotoxin positive stools in community acquired diarrhoea.

Authors:  D Burke; B J al Jumaili; H al Mardini; C O Record
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

4.  Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice.

Authors:  T Kurioka; Y Yunou; E Kita
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Shiga toxin-producing Escherichia coli-associated kidney failure in a 40-year-old patient and late diagnosis by novel bacteriologic and toxin detection methods.

Authors:  Louise D Teel; Brett R Steinberg; Naomi E Aronson; Alison D O'Brien
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Regulation of the Shiga-like toxin II operon in Escherichia coli.

Authors:  I Mühldorfer; J Hacker; G T Keusch; D W Acheson; H Tschäpe; A V Kane; A Ritter; T Olschläger; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

8.  Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response.

Authors:  P T Kimmitt; C R Harwood; M R Barer
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

9.  The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7.

Authors:  Suhui Zhao; Ying Zhou; Chunhui Wang; Yu Yang; Xianbo Wu; Yao Wei; Li Zhu; Wei Zhao; Qiwei Zhang; Chengsong Wan
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

Review 10.  Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.

Authors:  Chad L Mayer; Caitlin S Leibowitz; Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.